"Rutherford Cancer Centres is leading the way in transforming cancer care by providing innovative treatments and exceptional patient care and support. With our commitment to excellence and a patient-centric approach, the South Wales centre provides an all-encompassing cancer service, delivering innovative treatments including; proton beam therapy, radiotherapy, chemotherapy, immunotherapy and supportive care."

During the past decade, Rutherford Cancer Centre - South Wales conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rutherford Cancer Centre - South Wales" are "Breast Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Rutherford Cancer Centre - South Wales" in a lesser frequency.

Most popular intervention types in "Rutherford Cancer Centre - South Wales" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (1 trials), "Carboplatin" (1 trials), "Fulvestrant" (1 trials), "Inavolisib" (1 trials) and "Lazertinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rutherford Cancer Centre - South Wales" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rutherford Cancer Centre - South Wales". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rutherford Cancer Centre - South Wales, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rutherford Cancer Centre - South Wales, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".